Chemours公司与乔治亚4-H基金会合作 - Chemours公司与乔治亚4-H基金会合作提供环境教育和领导力学习给青少年[1] - Chemours公司将提供225,000美元资助支持乔治亚4-H的环境科学项目[2] - 乔治亚4-H每年有超过17万青少年参与活动，其中环境科学是课程的重要组成部分[3]

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the winners of its 2023 Responsible Supplier Awards. Chemours’ annual Responsible Supplier Award acknowledges the companies that have distinguished themselves by driving quality, innovation, and sustainability improvements across Chemours’ supply chain. Four Resp ...

The Chemours Company (NYSE:CC) Q3 2023 Earnings Conference Call October 27, 2023 8:00 AM ET Company Participants Brandon Ontjes - Vice President of FP&A and Investor Relations Mark Newman - President and Chief Executive Officer Jonathan Lock - Senior Vice President and Chief Financial Officer Conference Call Participants Duffy Fischer - Goldman Sachs John McNulty - BMO Capital Markets Josh Spector - UBS Hassan Ahmed - Alembic Global Advisors Laurence Alexander - Jefferies Vincent Andrews - Morgan Stanley Op ...

业绩总结 - Chemours公司第三季度净销售额下降16%，达到15亿美元[1] - Chemours公司第三季度调整后净收入为9600万美元，同比下降1亿美元[2] - Chemours公司第三季度调整后每股收益为0.63美元，同比下降0.61美元[3] - Chemours公司第三季度调整后EBITDA为2.47亿美元，同比下降1.16亿美元[4] - Chemours公司第三季度调整后自由现金流为8100万美元，同比下降1.48亿美元[5] 未来展望 - Chemours公司第三季度调整后每股收益指导范围更新为2.77至3.00美元[6] - TT转型计划预计将在2024年实现每年约1亿美元的节省[7] - 预计2023年第四季度TT需求将按照正常季节性模式下降[8] 新产品和新技术研发 - TSS业务净销售额同比增长，主要受Opteon™产品需求增加影响[9] - APM业务净销售额同比下降，主要是由于服务经济敏感端市场的高级材料组合需求减少[10] 市场扩张和并购 - TT转型计划预计将在2024年实现每年约1亿美元的节省[11] 负面信息 - 2023年投入资本回报率为18%，较2022年的34%有所下降[12]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 46-4845564 (State or other Jurisdiction of (I.R.S. Employer Incorporation or O ...

The Chemours Company (NYSE:CC) Q2 2023 Earnings Conference Call July 28, 2023 8:00 AM ET Company Participants Brandon Ontjes - Vice President of FP&A and Investor Relations Mark Newman - President and Chief Executive Officer Jonathan Lock - Chief Financial Officer Conference Call Participants Arun Viswanathan - RBC Capital Markets James Cannon - UBS Group AG Duffy Fischer - Goldman Sachs John McNulty - BMO Capital Markets Michael Leithead - Barclays John Roberts - Credit Suisse Jeff Zekauskas - JPMorgan Cha ...

Chemours 2Q 2023 Earnings Presentation Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 46-4845564 (State or other Jurisdiction of (I.R.S. Employer Incorporation or Organi ...

The Chemours Company (NYSE:CC) Q1 2023 Results Conference Call April 28, 2023 8:00 AM ET Company Participants Jonathan Lock - SVP and Chief Development Officer Mark Newman - CEO, President and Director Sameer Ralhan - Senior VP and CFO Conference Call Participants Duffy Fischer - Goldman Sachs Hassan Ahmed - Alembic Global Advisors John McNulty - BMO Capital Markets James Cannon - UBS Arun Viswanathan - RBC Capital Markets John Roberts - Credit Suisse William Tang - Morgan Stanley Laurence Alexander - Jeffe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36794 The Chemours Company (Exact Name of Registrant as Specified in Its Charter) Delaware 46-4845564 (State or other Jurisdiction of (I.R.S. Employer Incorporation or Organ ...